All lobbying filings

BAUSCH HEALTH COMPANIES

Lobbying for BAUSCH HEALTH COMPANIES

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $330,000.00 expenses · posted Apr 16, 2026

Official filing document

Bills named in this filing 1

HR 8267
Old Drugs, New Cures Act

Lobbying activity 1

Health Issues

General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.